Cefuracetime

• CAT Number: R029247
• CAS Number: 39685-31-9
• Molecular Formula: C₁₇H₁₇N₃O₈S
• Molecular Weight: 423.40
• Purity: ≥95%
• Synonyms: [6R-[6α,7β(Z)]]-3-[(Acetyloxy)methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; SKF 81367; Cefuroxime Sodium Impurity G (EP)
• Target: Bacterial
• Storage: -20°C
• IUPAC Name: (6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• InChI: InChI=1S/C17H17N3O8S/c1-8(21)28-6-9-7-29-16-12(15(23)20(16)13(9)17(24)25)18-14(22)11(19-26-2)10-4-3-5-27-10/h3-5,12,16H,6-7H2,1-2H3,(H,18,22)(H,24,25)/b19-11-/t12-,16-/m1/s1
• InChIKey: YBHZVPYSEUQIII-DYJQDLSISA-N
• SMILES: CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CC=CO3)SC1)C(=O)O

Cefuracetime（Cat No.:R029247）is a third-generation cephalosporin antibiotic, effective against a broad spectrum of Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, leading to cell lysis. It is commonly used to treat various bacterial infections, including respiratory tract infections, skin infections, and urinary tract infections. Due to its enhanced activity against β-lactamase-producing organisms, it offers improved efficacy over earlier cephalosporins. Cefuracetime is administered intravenously or intramuscularly and is often preferred in hospital settings for severe infections, where rapid bactericidal action is required.